Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 17 | 2022 | 2403 | 2.200 |
Why?
|
Carcinoma, Hepatocellular | 10 | 2024 | 2336 | 1.790 |
Why?
|
Living Donors | 6 | 2019 | 649 | 1.050 |
Why?
|
End Stage Liver Disease | 3 | 2022 | 370 | 0.950 |
Why?
|
Liver Neoplasms | 8 | 2024 | 4363 | 0.920 |
Why?
|
Hypertension, Renovascular | 2 | 2021 | 115 | 0.890 |
Why?
|
HSP40 Heat-Shock Proteins | 3 | 2024 | 85 | 0.880 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 2 | 2024 | 12 | 0.860 |
Why?
|
Aortic Diseases | 4 | 2020 | 741 | 0.840 |
Why?
|
Tissue Donors | 7 | 2022 | 2382 | 0.750 |
Why?
|
Arterial Occlusive Diseases | 3 | 2020 | 746 | 0.730 |
Why?
|
Aorta | 3 | 2020 | 2046 | 0.730 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 217 | 0.660 |
Why?
|
Hepatic Artery | 1 | 2019 | 232 | 0.620 |
Why?
|
Donor Selection | 2 | 2019 | 240 | 0.600 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2017 | 68 | 0.570 |
Why?
|
Organoids | 1 | 2022 | 745 | 0.530 |
Why?
|
Tissue Expansion Devices | 4 | 2020 | 160 | 0.520 |
Why?
|
Graft Survival | 10 | 2020 | 3888 | 0.480 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 4528 | 0.470 |
Why?
|
Vascular Surgical Procedures | 2 | 2020 | 1515 | 0.450 |
Why?
|
Aorta, Abdominal | 5 | 2018 | 627 | 0.450 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1616 | 0.440 |
Why?
|
Viscera | 1 | 2014 | 138 | 0.430 |
Why?
|
Up-Regulation | 1 | 2022 | 4148 | 0.410 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 269 | 0.410 |
Why?
|
Liver Regeneration | 1 | 2014 | 214 | 0.410 |
Why?
|
Mesentery | 1 | 2013 | 202 | 0.400 |
Why?
|
Esophagus | 2 | 2016 | 1043 | 0.380 |
Why?
|
Tissue Expansion | 3 | 2020 | 163 | 0.370 |
Why?
|
Epithelial Cells | 1 | 2022 | 3702 | 0.350 |
Why?
|
Liver | 5 | 2020 | 7578 | 0.350 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2014 | 335 | 0.350 |
Why?
|
Kidney Transplantation | 5 | 2019 | 4265 | 0.340 |
Why?
|
Abdominal Injuries | 1 | 2013 | 362 | 0.340 |
Why?
|
Intraoperative Care | 1 | 2013 | 771 | 0.330 |
Why?
|
Hospitals, Pediatric | 3 | 2020 | 1876 | 0.320 |
Why?
|
Mesenteric Arteries | 2 | 2020 | 178 | 0.320 |
Why?
|
Body Weight | 1 | 2019 | 4628 | 0.320 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1151 | 0.310 |
Why?
|
Phosphoproteins | 2 | 2018 | 2452 | 0.310 |
Why?
|
Aortic Valve Stenosis | 3 | 2018 | 2034 | 0.300 |
Why?
|
Organ Transplantation | 3 | 2017 | 1178 | 0.300 |
Why?
|
Biliary Tract | 1 | 2008 | 135 | 0.300 |
Why?
|
Thrombosis | 2 | 2019 | 2956 | 0.290 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2018 | 2911 | 0.280 |
Why?
|
Wounds, Nonpenetrating | 1 | 2013 | 807 | 0.270 |
Why?
|
Postoperative Complications | 6 | 2019 | 15889 | 0.260 |
Why?
|
Child | 22 | 2024 | 80960 | 0.260 |
Why?
|
Renal Artery | 2 | 2020 | 353 | 0.250 |
Why?
|
Child, Preschool | 18 | 2020 | 42683 | 0.250 |
Why?
|
Infant | 17 | 2020 | 36556 | 0.240 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 1524 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8664 | 0.240 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5804 | 0.230 |
Why?
|
Decision Support Techniques | 1 | 2013 | 2008 | 0.210 |
Why?
|
Cell Proliferation | 3 | 2016 | 10486 | 0.200 |
Why?
|
Syndrome | 5 | 2020 | 3274 | 0.200 |
Why?
|
Nephrectomy | 3 | 2019 | 949 | 0.200 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2024 | 1473 | 0.190 |
Why?
|
Kidney | 4 | 2021 | 7058 | 0.190 |
Why?
|
Alagille Syndrome | 1 | 2021 | 45 | 0.190 |
Why?
|
Pancreas Transplantation | 1 | 2022 | 193 | 0.190 |
Why?
|
Adolescent | 19 | 2024 | 89244 | 0.170 |
Why?
|
Humans | 49 | 2024 | 768970 | 0.170 |
Why?
|
Infant, Newborn | 7 | 2017 | 26428 | 0.170 |
Why?
|
Replantation | 1 | 2020 | 145 | 0.170 |
Why?
|
Immunophenotyping | 1 | 2024 | 1866 | 0.160 |
Why?
|
Iliac Artery | 1 | 2020 | 344 | 0.160 |
Why?
|
Treatment Outcome | 16 | 2024 | 65480 | 0.160 |
Why?
|
Biliary Atresia | 1 | 2019 | 88 | 0.150 |
Why?
|
Transplantation, Autologous | 2 | 2020 | 2126 | 0.150 |
Why?
|
Mitochondria | 2 | 2022 | 3682 | 0.150 |
Why?
|
Male | 32 | 2024 | 365203 | 0.150 |
Why?
|
Signal Transduction | 3 | 2018 | 23653 | 0.150 |
Why?
|
Hyperoxaluria, Primary | 1 | 2017 | 25 | 0.150 |
Why?
|
Oxalates | 1 | 2017 | 99 | 0.140 |
Why?
|
Kidney Failure, Chronic | 3 | 2019 | 2493 | 0.140 |
Why?
|
Herpesvirus 8, Human | 1 | 2019 | 256 | 0.140 |
Why?
|
Constriction, Pathologic | 3 | 2021 | 1104 | 0.140 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2016 | 39 | 0.140 |
Why?
|
Choledochostomy | 1 | 2016 | 16 | 0.130 |
Why?
|
Hepatoblastoma | 1 | 2017 | 90 | 0.130 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
Connective Tissue Growth Factor | 1 | 2016 | 91 | 0.130 |
Why?
|
Umbilical Veins | 1 | 2017 | 425 | 0.130 |
Why?
|
Cyclin E | 1 | 2016 | 156 | 0.130 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 375 | 0.130 |
Why?
|
Inflammation | 3 | 2020 | 10868 | 0.130 |
Why?
|
Blood Vessel Prosthesis | 1 | 2020 | 957 | 0.130 |
Why?
|
Abdominal Neoplasms | 1 | 2017 | 287 | 0.120 |
Why?
|
Time Factors | 6 | 2020 | 40261 | 0.120 |
Why?
|
Female | 28 | 2024 | 397515 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 1 | 2020 | 398 | 0.120 |
Why?
|
Retrospective Studies | 12 | 2020 | 81903 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2024 | 1094 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 628 | 0.110 |
Why?
|
Models, Animal | 3 | 2016 | 2122 | 0.110 |
Why?
|
Neurofibromatoses | 1 | 2018 | 303 | 0.110 |
Why?
|
Biotransformation | 1 | 2013 | 166 | 0.110 |
Why?
|
Anastomosis, Surgical | 2 | 2018 | 994 | 0.110 |
Why?
|
Liver Circulation | 1 | 2013 | 159 | 0.110 |
Why?
|
Organ Size | 2 | 2019 | 2268 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 420 | 0.110 |
Why?
|
Catheterization, Peripheral | 1 | 2017 | 347 | 0.110 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2017 | 327 | 0.100 |
Why?
|
Acid-Base Equilibrium | 1 | 2013 | 180 | 0.100 |
Why?
|
Learning Curve | 1 | 2015 | 232 | 0.100 |
Why?
|
Renal Veins | 1 | 2013 | 103 | 0.100 |
Why?
|
Mesenteric Artery, Superior | 1 | 2013 | 96 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2022 | 4290 | 0.100 |
Why?
|
Water-Electrolyte Balance | 1 | 2013 | 326 | 0.100 |
Why?
|
Age Factors | 3 | 2020 | 18435 | 0.100 |
Why?
|
Oncogene Proteins | 1 | 2016 | 718 | 0.100 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1163 | 0.100 |
Why?
|
Organogenesis | 1 | 2013 | 214 | 0.100 |
Why?
|
Heart Arrest | 1 | 2022 | 1515 | 0.100 |
Why?
|
Length of Stay | 2 | 2016 | 6526 | 0.100 |
Why?
|
Endovascular Procedures | 2 | 2018 | 2218 | 0.100 |
Why?
|
Hypertension | 4 | 2018 | 8617 | 0.090 |
Why?
|
Transplantation, Homologous | 3 | 2020 | 4835 | 0.090 |
Why?
|
Huntington Disease | 1 | 2018 | 1147 | 0.090 |
Why?
|
Boston | 4 | 2020 | 9377 | 0.090 |
Why?
|
Phosphorylation | 3 | 2021 | 8317 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2018 | 895 | 0.090 |
Why?
|
tau Proteins | 1 | 2021 | 2146 | 0.090 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12095 | 0.090 |
Why?
|
Duodenum | 1 | 2014 | 495 | 0.090 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2020 | 1459 | 0.090 |
Why?
|
Hepatectomy | 1 | 2014 | 588 | 0.090 |
Why?
|
Aortic Coarctation | 1 | 2012 | 278 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2021 | 3139 | 0.090 |
Why?
|
Angioplasty | 1 | 2013 | 357 | 0.090 |
Why?
|
Portal Vein | 1 | 2013 | 435 | 0.090 |
Why?
|
Vena Cava, Inferior | 1 | 2013 | 463 | 0.080 |
Why?
|
Risk Factors | 6 | 2019 | 74976 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9549 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1045 | 0.080 |
Why?
|
Stomach | 1 | 2014 | 702 | 0.080 |
Why?
|
Hepatocytes | 1 | 2016 | 1245 | 0.080 |
Why?
|
Renin-Angiotensin System | 1 | 2013 | 736 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2960 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2014 | 3588 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4756 | 0.070 |
Why?
|
Proteomics | 1 | 2022 | 3914 | 0.070 |
Why?
|
Biliary Tract Diseases | 1 | 2008 | 159 | 0.070 |
Why?
|
Creatinine | 1 | 2013 | 1917 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3450 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2016 | 2885 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13318 | 0.070 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2015 | 1027 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6547 | 0.070 |
Why?
|
Hippocampus | 1 | 2000 | 3782 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2000 | 3723 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2013 | 812 | 0.070 |
Why?
|
Infant, Premature | 1 | 2017 | 2123 | 0.070 |
Why?
|
Pediatrics | 2 | 2020 | 3628 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3811 | 0.070 |
Why?
|
Models, Biological | 1 | 2022 | 9499 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4265 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2018 | 12806 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8544 | 0.060 |
Why?
|
Liver Diseases | 1 | 2013 | 1305 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2228 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2297 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7609 | 0.060 |
Why?
|
Rats | 3 | 2016 | 23786 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3200 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 2027 | 0.050 |
Why?
|
Databases, Factual | 2 | 2016 | 8094 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2725 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3270 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39394 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2016 | 3800 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3592 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3313 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9519 | 0.050 |
Why?
|
Gene Fusion | 1 | 2024 | 357 | 0.050 |
Why?
|
Transcription Factors | 2 | 2018 | 12174 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4860 | 0.040 |
Why?
|
Choline | 1 | 2000 | 522 | 0.040 |
Why?
|
Motor Neurons | 1 | 2024 | 872 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1056 | 0.040 |
Why?
|
Ganciclovir | 1 | 2019 | 256 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 252 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 30046 | 0.040 |
Why?
|
14-3-3 Proteins | 1 | 2018 | 222 | 0.040 |
Why?
|
Waiting Lists | 1 | 2022 | 779 | 0.040 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2000 | 491 | 0.030 |
Why?
|
Recurrence | 1 | 2009 | 8513 | 0.030 |
Why?
|
Collateral Circulation | 1 | 2018 | 291 | 0.030 |
Why?
|
Portal Pressure | 1 | 2017 | 62 | 0.030 |
Why?
|
Pressure | 1 | 2020 | 1172 | 0.030 |
Why?
|
Albumins | 1 | 2019 | 577 | 0.030 |
Why?
|
Fluoxetine | 1 | 2000 | 733 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11932 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 422 | 0.030 |
Why?
|
Young Adult | 6 | 2024 | 60131 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 657 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2017 | 382 | 0.030 |
Why?
|
Animals | 6 | 2022 | 169335 | 0.030 |
Why?
|
Thrombelastography | 1 | 2017 | 194 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6805 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11262 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1500 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 463 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2016 | 8144 | 0.030 |
Why?
|
Platelet Count | 1 | 2017 | 787 | 0.030 |
Why?
|
Tissue and Organ Procurement | 2 | 2013 | 986 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2019 | 575 | 0.030 |
Why?
|
Adult | 7 | 2019 | 223851 | 0.030 |
Why?
|
Drug Resistance | 1 | 2000 | 1599 | 0.030 |
Why?
|
Frontal Lobe | 1 | 2000 | 1426 | 0.030 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2017 | 409 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1626 | 0.030 |
Why?
|
Risk Assessment | 2 | 2019 | 24333 | 0.030 |
Why?
|
Functional Laterality | 1 | 2000 | 2267 | 0.030 |
Why?
|
Ureterostomy | 1 | 2013 | 18 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2000 | 6030 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4207 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 643 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2080 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2003 | 2634 | 0.030 |
Why?
|
Aged | 3 | 2021 | 171786 | 0.030 |
Why?
|
Hyperplasia | 1 | 2016 | 1154 | 0.030 |
Why?
|
Middle Aged | 4 | 2021 | 223737 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3629 | 0.020 |
Why?
|
Synapses | 1 | 2021 | 1764 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2009 | 11684 | 0.020 |
Why?
|
Paclitaxel | 1 | 2019 | 1735 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27453 | 0.020 |
Why?
|
Hemoglobins | 1 | 2017 | 1531 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2126 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2000 | 3782 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1309 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4545 | 0.020 |
Why?
|
Liver Failure | 1 | 2012 | 252 | 0.020 |
Why?
|
Cohort Studies | 3 | 2019 | 41808 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2000 | 2649 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1962 | 0.020 |
Why?
|
Brain Death | 1 | 2012 | 359 | 0.020 |
Why?
|
Cadaver | 1 | 2013 | 1366 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3629 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12562 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2748 | 0.020 |
Why?
|
Macrophages | 1 | 2003 | 5801 | 0.020 |
Why?
|
Gestational Age | 1 | 2017 | 3621 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2012 | 505 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 30266 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10115 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9344 | 0.020 |
Why?
|
Intestine, Small | 1 | 2012 | 1218 | 0.020 |
Why?
|
Radiography | 1 | 2017 | 6991 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3591 | 0.020 |
Why?
|
Graft Rejection | 1 | 2019 | 4492 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 17173 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15951 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 36854 | 0.010 |
Why?
|
United States | 3 | 2018 | 73186 | 0.010 |
Why?
|
Vasa Vasorum | 1 | 2003 | 25 | 0.010 |
Why?
|
Angiostatins | 1 | 2003 | 64 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 9080 | 0.010 |
Why?
|
Plasminogen | 1 | 2003 | 144 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13674 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 751 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8559 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9621 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9684 | 0.010 |
Why?
|
Depression | 1 | 2000 | 8231 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15471 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 674 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2003 | 606 | 0.010 |
Why?
|
Receptors, LDL | 1 | 2003 | 492 | 0.010 |
Why?
|
Lymphokines | 1 | 2003 | 927 | 0.010 |
Why?
|
Inositol | 1 | 2000 | 216 | 0.010 |
Why?
|
Feedback | 1 | 2003 | 799 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18354 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21547 | 0.010 |
Why?
|
Creatine | 1 | 2000 | 427 | 0.010 |
Why?
|
Mice | 2 | 2022 | 82072 | 0.010 |
Why?
|
Aspartic Acid | 1 | 2000 | 577 | 0.010 |
Why?
|
Cytosol | 1 | 2000 | 886 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2003 | 1461 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18068 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59739 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1658 | 0.010 |
Why?
|
Monocytes | 1 | 2003 | 2603 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54962 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 3518 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6346 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2003 | 5151 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20776 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2003 | 14484 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2003 | 22379 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2000 | 22296 | 0.000 |
Why?
|